Inventor Designs Oxygen Aid for Post-Surgery Patients (SUU-431)
PITTSBURGH, Jan. 19, 2018 /PRNewswire/ -- Since there's no way to administer oxygen to patients that are being transferred to a recovery location, an inventor from Park Hills, Mo., decided that there should be a way to keep oxygen delivery constant instead of interrupting it in such a situation.
The patent-pending OXYGEN CAP allows for better oxygen administration for a patient during transport to the recovery room. It eliminates interruption of oxygen aid, which helps improve the safety and health of the patient. As a result, it promotes efficiency and peace of mind.
Ergonomic and easy to use, the OXYGEN CAP is suitable for anesthesia technicians and recovery-room nurses and is usable with laryngeal mask airway devices.
The original design was submitted to the Salt Lake City office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 16-SUU-431, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com - https://www.youtube.com/user/inventhelp
HanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models" in the Nature...
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed two contracts to provide the radiology module of its enterprise imaging solution with two university medical centers in Germany?Universitätsklinikum Tübingen...
Today, 23 April 2024, the subscription period in SciBase Holding AB (publ) ('SciBase' or the 'Company') rights issue of units of up to approximately SEK 15 million commences (the 'Rights Issue'). The Rights Issue was resolved by the Board of...
Antech, the veterinary diagnostics company focused on partnering with veterinary professionals to predict, diagnose, and monitor wellness and disease, today announced the launch of the breakthrough in-hospital Nu.Q® Canine Cancer Test in Europe. A...
Red Arrow Therapeutics Inc. closed a $4.5M Seed Extension round, raising from four, top-tier institutional investors in Japan.
Participants of this round are:
Beyond Next Ventures Inc.The University of Tokyo Edge Capital Partners Co., Ltd.Keio...
Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care...
